TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types.
- DOI
- 10.21037/tcr.2019.07.36
- Published
- 2019 Aug
- Container
- Translational cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/tcr.2019.07.36,
title = {TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types.},
author = {Paucarmayta A and Taitz H and Casablanca Y and Rodriguez GC and Maxwell GL and Darcy KM and Syed V},
year = {2019},
journal = {Translational cancer research},
doi = {10.21037/tcr.2019.07.36},
url = {https://doi.org/10.21037/tcr.2019.07.36}
}RIS
TY - JOUR TI - TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types. AU - Paucarmayta A AU - Taitz H AU - Casablanca Y AU - Rodriguez GC AU - Maxwell GL AU - Darcy KM AU - Syed V PY - 2019 JO - Translational cancer research DO - 10.21037/tcr.2019.07.36 UR - https://doi.org/10.21037/tcr.2019.07.36 ER -
APA
A, P., H, T., Y, C., GC, R., GL, M., KM, D., & V, S. (2019). TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types.. Translational cancer research. https://doi.org/10.21037/tcr.2019.07.36
Source records
- pubmed · retrieved 2026-09-25T06:00:37.397Z